Cargando…

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Detalles Bibliográficos
Autores principales:	Monda, Vincenzo M., Porcellati, Francesca, Strollo, Felice, Gentile, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400747/ https://www.ncbi.nlm.nih.gov/pubmed/32749644 http://dx.doi.org/10.1007/s13300-020-00898-8

Ejemplares similares

Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
por: Monda, Vincenzo Maria, et al.
Publicado: (2022)

Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
por: Monda, Vincenzo Maria, et al.
Publicado: (2021)

Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
por: Monda, Vincenzo M., et al.
Publicado: (2023)

Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
por: Strollo, Felice, et al.
Publicado: (2017)

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
por: Gentile, Sandro, et al.
Publicado: (2020)

Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
por: Gentile, Sandro, et al.
Publicado: (2020)

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
por: Østergaard, Jakob A., et al.
Publicado: (2022)

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
por: Giugliano, Dario, et al.
Publicado: (2021)

GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata
por: Goggins, Michael
Publicado: (2012)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
por: La Vignera, Sandro, et al.
Publicado: (2020)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
por: Pang, Juan, et al.
Publicado: (2021)

Effects of cigarette smoking on SARS‐CoV‐2 receptor ACE2 expression in the respiratory epithelium(†)
por: Heijink, Irene H, et al.
Publicado: (2021)

Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary
por: Costagliola, Anna, et al.
Publicado: (2020)

Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021)

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
por: Biagioli, Michele, et al.
Publicado: (2021)

GLP-2 cures the gut – What about the liver?
por: Pakarinen, Mikko P.
Publicado: (2019)

Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? – GLP-1 might play one too
por: Morin, Nathaniel
Publicado: (2020)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
por: Gentile, Sandro, et al.
Publicado: (2016)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

A lethal mouse model using a mouse-adapted SARS-CoV-2 strain with enhanced binding to mouse ACE2 as an important platform for COVID-19 research
por: Chu, Hin, et al.
Publicado: (2021)

Recent Progress in Space Physiology and Aging
por: Strollo, Felice, et al.
Publicado: (2018)

Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
por: Mehrabadi, Maryam Eskandari, et al.
Publicado: (2021)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
por: Darsalia, Vladimer, et al.
Publicado: (2018)

Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes
por: Porcellati, Francesca, et al.
Publicado: (2013)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
por: Salamanna, Francesca, et al.
Publicado: (2020)

SARS-CoV-2: the “Uncensored” Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon
por: Gentile, Pietro
Publicado: (2021)

COVID-19, diabetes mellitus and ACE2: The conundrum
por: Pal, Rimesh, et al.
Publicado: (2020)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD
por: Guarino, Giuseppina, et al.
Publicado: (2023)

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases
por: Bank, Sarbashri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mk8qn986odj5ikkv5frc6gh6pu